Indiana Trust & Investment Management Co Decreases Stock Holdings in Colgate-Palmolive (NYSE:CL)

Indiana Trust & Investment Management Co cut its position in Colgate-Palmolive (NYSE:CLFree Report) by 17.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,185 shares of the company’s stock after selling 252 shares during the quarter. Indiana Trust & Investment Management Co’s holdings in Colgate-Palmolive were worth $108,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive during the 4th quarter valued at about $32,000. Hager Investment Management Services LLC purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $36,000. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the third quarter valued at about $42,000. Synergy Asset Management LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $49,000. Finally, Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive in the 3rd quarter worth approximately $53,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $87.35 on Wednesday. The stock has a market capitalization of $71.37 billion, a P/E ratio of 24.82, a P/E/G ratio of 4.12 and a beta of 0.44. The company’s fifty day moving average price is $90.14 and its 200 day moving average price is $96.69. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the business earned $0.87 EPS. As a group, equities research analysts anticipate that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.29%. Colgate-Palmolive’s payout ratio is currently 56.82%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. TD Cowen decreased their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. UBS Group lowered their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $101.16.

View Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.